Peter Boris Centre for Addictions Research, McMaster University/St. Joseph's Healthcare Hamilton.
Department of Psychology, University of Memphis.
Exp Clin Psychopharmacol. 2022 Oct;30(5):584-592. doi: 10.1037/pha0000485. Epub 2021 Jun 7.
Cannabis use is prevalent and concerns about cannabis misuse are increasing. A reinforcer pathology approach emphasizes the roles of drug reinforcing value (demand) and overvaluation of immediate rewards (delay discounting [DD]) in drug use but has been applied to a lesser extent to cannabis. The present study investigated the independent and interactive roles of these processes in relation to cannabis misuse in a community sample of adult cannabis users (N = 324; 44.8% female; M = 33.25). Participants completed a Marijuana Purchase Task (MPT), the Monetary Choice Questionnaire (MCQ), and the Cannabis Use Disorder Identification Test-Revised (CUDIT-R) to assess demand, DD, and cannabis misuse, respectively. Zero-order correlations revealed significant associations between CUDIT-R scores and both the demand indices (|r | = .21-.56, p < .01-.001) and DD (r = .21, p < .01). In multivariate analyses, lower elasticity (i.e., price insensitivity) was robustly associated with higher CUDIT-R scores, while other demand indicators did not explain additional unique variance. However, as elasticity, intensity, and O exhibited robust zero-order intercorrelations, shared variance appeared to drive the association. An interactive relationship between elasticity and DD was not significant. These findings indicate that cannabis misuse is associated with both cannabis demand, particularly as measured by insensitivity to escalating costs, and immediate reward orientation, but the relationship was not synergistic. These results support a reinforcer pathology approach to cannabis misuse and, although causality cannot be inferred cross-sectionally, suggest that evaluating the longitudinal significance of these indicators is warranted. (PsycInfo Database Record (c) 2022 APA, all rights reserved).
大麻的使用非常普遍,人们对大麻滥用的担忧也在与日俱增。强化病理方法强调了药物强化价值(需求)和即时奖励高估(延迟折扣[DD])在药物使用中的作用,但在大麻方面的应用相对较少。本研究在一个成年大麻使用者的社区样本中(N=324;44.8%为女性;M=33.25),调查了这些过程在与大麻滥用有关的独立和相互作用的作用。参与者完成了大麻购买任务(MPT)、货币选择问卷(MCQ)和大麻使用障碍识别测试修订版(CUDIT-R),分别评估需求、DD 和大麻滥用。零阶相关显示,CUDIT-R 评分与需求指数(|r|=.21-.56,p<.01-.001)和 DD(r=.21,p<.01)之间存在显著关联。在多元分析中,较低的弹性(即对价格不敏感)与较高的 CUDIT-R 评分显著相关,而其他需求指标则无法解释额外的独特差异。然而,由于弹性、强度和 O 之间存在稳健的零阶相互关联,因此共享方差似乎驱动了这种关联。弹性和 DD 之间的交互关系不显著。这些发现表明,大麻滥用与大麻需求有关,特别是与对成本不断上升的不敏感有关,以及即时奖励取向有关,但这种关系并不是协同的。这些结果支持大麻滥用的强化病理方法,尽管不能从横截面上推断因果关系,但表明有必要评估这些指标的纵向意义。(PsycInfo 数据库记录(c)2022 APA,保留所有权利)。